Medeon Biodesign (ROCO:6499) Interest Expense : NT$-4.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medeon Biodesign's interest expense for the three months ended in Mar. 2024 was NT$ -1.5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-4.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medeon Biodesign's Operating Income for the three months ended in Mar. 2024 was NT$ -226.3 Mil. Medeon Biodesign's Interest Expense for the three months ended in Mar. 2024 was NT$ -1.5 Mil. Medeon Biodesign did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medeon Biodesign Interest Expense Historical Data

The historical data trend for Medeon Biodesign's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Interest Expense Chart

Medeon Biodesign Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.01

-2.74

-1.39

-1.03

-5.21

Medeon Biodesign Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1.69	-1.80	-1.70	-1.62	-1.52

Medeon Biodesign Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-4.8 Mil.

Medeon Biodesign (ROCO:6499) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medeon Biodesign's Interest Expense for the three months ended in Mar. 2024 was NT$-1.5 Mil. Its Operating Income for the three months ended in Mar. 2024 was NT$-226.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was NT$152.8 Mil.

Medeon Biodesign's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Medeon Biodesign did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Medeon Biodesign (ROCO:6499) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170

Website

http://www.medeonbio.com

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign (ROCO:6499) Headlines

No Headlines